InMode Ltd. (INMD) Q4 2025 Earnings Call Transcript

InMode Ltd. ( INMD) Q4 2025 Earnings Call February 10, 2026 8:30 AM EST ...
Seeking Alpha

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories

IRVINE, Calif., Oct. 24, 2024 /PRNewswire/ -- InMode Ltd. (INMD), a leading global provider of innovative medical technologies, has been granted a preliminary injunction by the U.S. District Court for ...
Morningstar

InMode to Report First Quarter 2025 Financial Results and Hold Conference Call on April 28, 2025, Expects Q1 Revenue Between $77.2M-$77.5M, Reiterates FY 2025 Revenue Guidance ...

InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a ...

InMode reports revenue dip, plans share repurchase

YOKNEAM, Israel - InMode Ltd . (NASDAQ:INMD), a global provider of medical technology currently trading significantly below InvestingPro's Fair Value estimate, disclosed its financial results for the ...
Morningstar

InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025

InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, ...
Insider Monkey

InMode Ltd. (NASDAQ:INMD) Q2 2025 Earnings Call Transcript

InMode Ltd. beats earnings expectations. Reported EPS is $0.47, expectations were $0.43. Operator: Good day, and welcome to InMode’s Second Quarter 2025 Earnings Results Conference Call. [Operator ...